Last update 26 Aug 2025

Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal)

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms
Anti-minor Histocompatibility Complex Donor T-lymphocytes(CIUSSS de l'Est de l'ile de Montreal)
Target-
Action-
Mechanism
Immunologic cytotoxicity
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
Acute Biphenotypic LeukemiaAdult Acute Myeloblastic LeukemiaMyelodysplastic Syndromes+ [5]
Originator Organization
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
Active Organization-
Inactive Organization
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal)
NCT03091933
/ Unknown statusPhase 1/2IIT
An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Anti-minor Histocompatibility Complex (MiHA) Donor T-lymphocytes Expanded ex Vivo, in Patients With a Hematologic Malignancy, With Molecular or Clinical Relapse After Hematopoietic Stem Cell Transplantation From a Matched Donor
100 Clinical Results associated with Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal)
Login to view more data
100 Translational Medicine associated with Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal)
Login to view more data
100 Patents (Medical) associated with Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal)
Login to view more data
100 Deals associated with Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Biphenotypic LeukemiaPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Adult Acute Myeloblastic LeukemiaPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Myelodysplastic SyndromesPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Recurrent Adult Acute Lymphoblastic LeukemiaPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Recurrent Chronic Lymphoid LeukemiaPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Recurrent Hodgkin LymphomaPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Recurrent Non-Hodgkin LymphomaPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Relapse multiple myelomaPhase 2
Canada
CIUSSS de l’Est-de-l’Île-de-MontréalCIUSSS de l’Est-de-l’Île-de-Montréal
06 Feb 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free